Transaction · 0001415889-25-002134

Peetz Christopher

Peetz Christopher, CEO, reported an open-market or private sale at Mirum Pharmaceuticals, Inc. involving 6837.000000 shares for an estimated $327658.44. Reported holdings after the transaction were 125022.000000 shares. A 10b5-1 reference was not detected in the stored filing text.

Open-market sellSEC transaction code SCEO
MIRMMirum Pharmaceuticals, Inc.
Filing timeJan 27
Trade dateJan 24, 2025
Filing · SECView on SEC
InsiderProfile

Price performance since filing

Close on the filing date, the pre-filing context, and the forward return at standard windows
Price at filing
—
Pre-filing
1mo ago1w ago1d ago
Returns since
7d30d90d180d1y

MIRM price since this filing

30 days of pre-filing context and vertical markers at the filing date plus 7d / 30d / 90d / 180d / 1y afterwards
MIRM since 2025-01-27Filed 585 days ago · 30 days of pre-filing context shaded
Loading…
Filing datePost-filing windows (7d, 30d, 90d, 180d, 1y)30 days of pre-filing context

Transaction facts

Stored Form 4 columns with their raw values

Non-derivative
Type
Sell
Code S
Identifier
0001415889-25-002134
Common Stock
Transaction date
Jan 24, 2025
Filed Jan 27, 2025, 09:48 PM · 3d delay
Shares
6.83k sh
$4.79k per share
Estimated value
-$32.7M
Computed from shares × price
Holdings after
125k sh
Direct

Filing signal explanations

Badges describe filing facts only — not predictions.

Cluster 14dRepeat 30dPattern $10.0MLarge $100M
Cluster Selling Direct Ownership Repeat Seller
+6score
Filing-only score

+6

Compact filing score computed from stored Form 4 facts. Version v1.

Positive filing signal

This filing has a modest positive filing-only score. Treat it as a useful flag for review, not as a buy signal.

Reported relationships & other filings

Form 4 relationship flags and nearby filing context

Reported roles

CHIEF EXECUTIVE OFFICER

Officer YesDirector Yes10% NoOther No
Footnotes & amended
  1. F1

    Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock.

  2. F2

    Shares sold to cover tax withholding obligations associated with the vesting of restricted stock units.

  3. F3

    1/3rd of the shares subject to the restricted stock units shall vest on each anniversary of January 23, 2024 (the "Vesting Commencement Date"), such that the entire award will be vested on the three-y…

Original filing · 0001415889-25-002134
Related transactions

0 other filings

Same reporting owner
Recent company activity

0 recent txs

MIRM